Award recordCONTRACT

ACORDA THERAPEUTICS, INC.

PIID 36E79723A0011· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2023· $0 net obligations· UEI R5D3FUPFFPK4· NY

Description

BPA CANCELLATION

Base award description: BPA FOR INBRIJA, AMPYRA

First action · last action
2023-01-26 · 2024-01-11
Transactions
2
First transaction's obligation
$0
Base + all options value (sum of deltas)
$7,500,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0361
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2023-01-26 · this action $0 · running total $0Modification P00001 · 2024-01-11 · this action $0 · running total $0
  • Base2023-01-26+$0= $0
  • Mod P000012024-01-11+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-01-26+$0$0BPA FOR INBRIJA, AMPYRA
Mod P00001· LEGAL CONTRACT CANCELLATION2024-01-11+$0$0BPA CANCELLATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI R5D3FUPFFPK4)

AwardOffice · PSC / listingNet obligationsFY
36C77024N0067NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$493,607FY2024
36E79724A0005NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C77024N0027NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$444,505FY2024
36F79723D0194NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C77023N0057NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$529,877FY2023
36C77022N0169NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$158,963FY2022

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79723A0011_3600 · retrieved 2026-09-26.